News

Born with congenital heart disease, Christin Murphy, 41, was familiar with cardiology appointments, stress tests, and surgeries.

Chandler DeBolt needed immediate attention but had extremely limited options before his family was referred to the Adult Congenital Heart Disease program at Saint Luke’s Mid America Heart Institute in Kansas City.

Alexis Ellington has a renewed outlook on life after being the first Saint Luke's patient to receive a new cancer treatment called Bispecific T-cell Engagers therapy, or BiTE.

Dr. Tim Pluard talks about an exciting expansion that will make cancer care more accessible to Kansas City’s growing Northland community.

Largest systematic study of atherosclerosis in ancient human remains suggests innate human predisposition to heart disease.

We are talking about lung cancer and how precision oncology helps patients diagnosed with the disease with treatment.

Local anchor, Christel Bell, came to Saint Luke's Hospital of Kansas City when she knew something wasn't right.

The Koontz Center has cared for hundreds of patients with Stage 4 metastatic breast cancer since its inception in 2016.

Over the years, they have done everything together: graduated high school, tied the knot, bought their first home, and raised a family. For all they have shared, they never dreamed of sharing a cancer diagnosis.